论文部分内容阅读
国家“九五”期间重点项目国家新药筛选中心奠基典礼近日在浦东张江高科技园区举行。该中心由科技部、中国科学院和上海市政府共同投资建设,旨在加强国家生物医药科技产业基地的建设、推进建立生物医药创新体系。国家新药筛选中心由中科院上海药物所所长、我国首批11名首席科学家之一陈凯先任理事长。该中心将以我国重要疾病的防治为重点,建立并发展国际领先技术的药物筛选模型,初步形成我国自主的药物筛选体系。与此同时兴建的国家上海新药安全评价研究中心,除承担一般毒理、遗传毒理等安全评价研究工作外,还将开展化学品致癌性的安全评价研究。
The foundation stone laying ceremony of the national new drug screening center for key projects during the Ninth Five-year Plan period was held in Zhangjiang Hi-Tech Park in Pudong recently. The center by the Ministry of Science and Technology, Chinese Academy of Sciences and the Shanghai municipal government jointly invest in building, aimed at strengthening the national biomedical science and technology industrial base construction, and promote the establishment of biomedical innovation system. National Drug Screening Center by the Shanghai Institute of Materia Medica Chinese Academy of Sciences, China’s first batch of 11 Chief Scientist Chen Kai first chairman. The center will focus on the prevention and treatment of important diseases in our country, establish and develop the international advanced drug screening model, and initially form the independent drug screening system in our country. At the same time, the state-level Shanghai New Drug Safety Evaluation Research Center, which is also under construction, will carry out safety evaluation studies on carcinogenicity of chemicals in addition to undertaking safety evaluation studies on general toxicological and genetic toxicology.